⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6701636 | 0.83 | ALOX15 (0.32) | — | |
| SCHEMBL430949 | 0.81 | — | — | |
| SCHEMBL1289421 | 0.78 | MEN1 (0.32) | — | |
| SCHEMBL419805 | 0.78 | MEN1 (0.32) | — | |
| SCHEMBL6965978 | 0.74 | — | — | |
| SCHEMBL292853 | 0.73 | — | — | |
| SCHEMBL431029 | 0.73 | — | — | |
| SCHEMBL6959387 | 0.72 | — | — | |
| SCHEMBL9939446 | 0.71 | — | — | |
| SCHEMBL5579 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 151 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110678447-B | Modified nucleic acid monomer compounds and oligonucleotide analogues | 卫材R&D管理有限公司 | 2023-12-12 | — | — | CN | claimed |
| EP-3630738-A1 | PROCESS FOR THE PRODUCTION OF OZANIMOD | Egis Gyógyszergyár Zrt. (HU) | 2020-04-08 | — | — | EP | claimed |
| WO-2018215807-A1 | PROCESS FOR THE PRODUCTION OF OZANIMOD | EGIS GYÓGYSZERGYÁR ZRT. (HU) | 2018-11-29 | — | — | WO | claimed |
| US-20120077798-A1 | AZETIDINE AND CYCLOBUTANE DERIVATIVES AS JAK INHIBITORS | INCYTE CORPORATION | 2012-03-29 | — | — | US | claimed |
| EP-2288610-A1 | AZETIDINE AND CYCLOBUTANE DERIVATIVES AS JAK INHIBITORS | Incyte Corporation (US) | 2011-03-02 | — | — | EP | claimed |
| WO-2009114512-A1 | AZETIDINE AND CYCLOBUTANE DERIVATIVES AS JAK INHIBITORS | INCYTE CORPORATION (US) | 2009-09-17 | — | — | WO | claimed |
| US-20090233903-A1 | AZETIDINE AND CYCLOBUTANE DERIVATIVES AS JAK INHIBITORS | INCYTE CORPORATION (US) | 2009-09-17 | — | — | US | claimed |
| EP-0711773-A1 | HYMENIALDISINE AND DERIVATIVE THEREOF, PROCESS FOR PRODUCING INTERMEDIATE FOR SYNTHESIZING THE SAME, AND SAID INTERMEDIATE | SUNTORY LIMITED (JP) | 1996-05-15 | — | — | EP | claimed |
| EP-4362933-A1 | COMPLEMENT INHIBITION | Apellis Pharmaceuticals, Inc. (US) | 2024-05-08 | — | — | EP | disclosed |
| WO-2024054669-A2 | COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF NUCLEIC ACID-BASED THERAPEUTICS AND METHODS THEREOF | NANOTECH PHARMA INC. (US) | 2024-03-14 | — | — | WO | disclosed |
| US-20240059679-A1 | GLP-1 Receptor Agonists and Uses Thereof | PFIZER INC. (US) | 2024-02-22 | — | — | US | disclosed |
| CN-110678447-B | Modified nucleic acid monomer compounds and oligonucleotide analogues | 卫材R&D管理有限公司 | 2023-12-12 | — | — | CN | disclosed |
| EP-3643706-B1 | MODIFIED NUCLEIC ACID MONOMERS AND OLIGONUCLEIC ACID ANALOGUES, WITH HIGH BIOLOGICAL STABILITY AND TARGET GENE SILENCING ACTIVITY, FOR USE IN THERAPY AND DIAGNOSIS OF CANCER AND VIRAL DISEASES | EISAI R&D MAN CO LTD (JP) | 2023-11-15 | — | — | EP | disclosed |
| WO-2023210623-A1 | HALOALKYL SULFONE ANILIDE COMPOUND AND HERBICIDE CONTAINING SAME | 株式会社エス・ディー・エス バイオテック | 2023-11-02 | — | — | WO | disclosed |
| US-6693193-B1 | COUPLING AN N- AND O-PROTECTED 2,3-DIHYDROXY-PYRROLIDINE TO THE 2-POSITION AND DEPROTECTING | INDUSTRIAL RESEARCH LIMITED (NZ) | 2004-02-17 | — | — | US | disclosed |
| US-6084081-A | Lewis X derivatives | DAIKIN INDUSTRIES, LTD. (JP) | 2000-07-04 | — | — | US | disclosed |
| WO-1999065881-A1 | HETEROCYCLIC COMPOUNDS AS HYPOGLYCEMIC AGENTS | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 1999-12-23 | — | — | WO | disclosed |
| EP-0930315-A1 | LEWIS X DERIVATIVES | DAIKIN INDUSTRIES, LTD. (JP) | 1999-07-21 | — | — | EP | disclosed |
| WO-1994003439-A1 | ANTIPROLIFERATIVE TRICYCLIC COMPOUNDS | AGOURON PHARMACEUTICALS, INC. (US) | 1994-02-17 | — | — | WO | disclosed |
| EP-0437508-A4 | NON-PEPTIDE RENIN INHIBITORS | — | 1991-11-06 | — | — | EP | disclosed |